Alector, Inc. (ALEC)
NASDAQ
Key stats Fiscal year 2025
Income statement
- Revenue
- 21,045,000 -79.1%
- Net income
- -142,929,000
- Operating income
- -156,007,000
- Earnings per share
- -1.39
- R&D expense
- 123,065,000
Growth and profitability
- Operating margin
- -741.30
- Net margin
- -679.16
- Return on equity
- -466.34
- Return on assets
- -48.74
- Free cash flow margin
- -874.66
Balance sheet
- Total assets
- 293,237,000
- Total liabilities
- 262,588,000
- Shareholders' equity
- 30,649,000
- Cash and equivalents
- 65,802,000
- Debt
- 10,000,000
- Net debt
- -55,802,000
- Current ratio
- 3.83
- Debt to equity
- 0.33
Cash flow and ratios
- Operating cash flow
- -184,031,000
- Free cash flow
- -184,072,000
Shareholder returns
- Shares outstanding
- 148,877,074
- Book value per share
- 0.21
Company information
- Headquarters
- South San Francisco, CA
- Exchange
- NASDAQ
- Fiscal year end
- 12-31
- Industry (SEC)
- Biological Products, (no Diagnostic Substances)
Fiscal year end: · Source: SEC EDGAR
Alector, Inc. trades on NASDAQ under the ticker symbol ALEC. This page brings together its price chart, company profile, key financial figures and technical indicators.